No Data
Veracyte Announces New Data Showing That Its Whole-Genome Sequencing (Wgs)-Based Platform For Minimal Residual Disease Testing Detected Cancer In Patients Treated for Muscle-Invasive Bladder Cancer With More Accuracy Than Ddpcr-Based Blood Testing And...
Merck Inks a Licensing Deal Worth Nearly $2B With China's Jiangsu Hengrui
Alnylam Pharmaceuticals Presents 'Convincing Multi-Billion Dollar Opportunity': Analyst Upgrades Stock
Carnival To Rally Around 48%? Here Are 10 Top Analyst Forecasts For Monday
Robinhood, Roku And Shopify Are Among Top 10 Large-Cap Gainers Last Week (Mar 17-Mar 21): Are The Others In Your Portfolio?
Alnylam's Amvuttra Secures FDA Approval For Expanded Use For Rare Heart Disease, Stock Jumps
lightfoot : junk, hook, line and sinker
Wonder-Man : great post. thank you for sharing
Christopher Flint197 : like to learn what a swing trade looks like and when to get in and out.